Clinical Trial: A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: Safety, Tolerability and Pharmacokinetics of Single Subcutaneous Doses of BI 3034701 in Healthy Male Volunteers (Part A) and of Multiple Rising Subcutaneous Doses in Otherwise Healthy Male and Female
Brief Summary:
This study is open to healthy people and people with overweight or obesity.It has 2 parts.Part A is open to healthy men between 18 and 55 years of age.Part B is open to people between 18 and 65 years of age with overweight or obesity who are otherwise healthy.The purpose of this study is to find out how well different doses of BI 3034701 are tolerated by healthy men (Part A) and people with overweight or obesity (Part B).Another goal of this study is to find out how different doses of BI 3034701 are taken up in…
Read more